169 related articles for article (PubMed ID: 35969506)
1. Artificial Antigen-Presenting Cell Topology Dictates T Cell Activation.
Wauters AC; Scheerstra JF; Vermeijlen IG; Hammink R; Schluck M; Woythe L; Wu H; Albertazzi L; Figdor CG; Tel J; Abdelmohsen LKEA; van Hest JCM
ACS Nano; 2022 Sep; 16(9):15072-15085. PubMed ID: 35969506
[TBL] [Abstract][Full Text] [Related]
2. PEGylated and CD47-conjugated nanoellipsoidal artificial antigen-presenting cells minimize phagocytosis and augment anti-tumor T-cell responses.
Song S; Jin X; Zhang L; Zhao C; Ding Y; Ang Q; Khaidav O; Shen C
Int J Nanomedicine; 2019; 14():2465-2483. PubMed ID: 31040669
[TBL] [Abstract][Full Text] [Related]
3. Biologically Inspired Design of Nanoparticle Artificial Antigen-Presenting Cells for Immunomodulation.
Hickey JW; Vicente FP; Howard GP; Mao HQ; Schneck JP
Nano Lett; 2017 Nov; 17(11):7045-7054. PubMed ID: 28994285
[TBL] [Abstract][Full Text] [Related]
4. Nanoscale artificial antigen presenting cells for cancer immunotherapy.
Rhodes KR; Green JJ
Mol Immunol; 2018 Jun; 98():13-18. PubMed ID: 29525074
[TBL] [Abstract][Full Text] [Related]
5. Shape matters: Biodegradable anisotropic nanoparticle artificial antigen presenting cells for cancer immunotherapy.
Ben-Akiva E; Hickey JW; Meyer RA; Isser A; Shannon SR; Livingston NK; Rhodes KR; Kosmides AK; Warren TR; Tzeng SY; Schneck JP; Green JJ
Acta Biomater; 2023 Apr; 160():187-197. PubMed ID: 36812956
[TBL] [Abstract][Full Text] [Related]
6. Particle-Based Artificial Antigen-Presenting Cell Systems for T Cell Activation in Adoptive T Cell Therapy.
Hou F; Guo Z; Ho MT; Hui Y; Zhao CX
ACS Nano; 2024 Mar; 18(12):8571-8599. PubMed ID: 38483840
[TBL] [Abstract][Full Text] [Related]
7. Cell-Sized Lipid Vesicles as Artificial Antigen-Presenting Cells for Antigen-Specific T Cell Activation.
Chen JY; Agrawal S; Yi HP; Vallejo D; Agrawal A; Lee AP
Adv Healthc Mater; 2023 May; 12(12):e2203163. PubMed ID: 36645182
[TBL] [Abstract][Full Text] [Related]
8. Particle shape dependence of CD8+ T cell activation by artificial antigen presenting cells.
Sunshine JC; Perica K; Schneck JP; Green JJ
Biomaterials; 2014 Jan; 35(1):269-277. PubMed ID: 24099710
[TBL] [Abstract][Full Text] [Related]
9. Biodegradable Cationic Polymer Blends for Fabrication of Enhanced Artificial Antigen Presenting Cells to Treat Melanoma.
Rhodes KR; Isser A; Hickey JW; Ben-Akiva E; Meyer RA; Kosmides AK; Livingston NK; Tzeng SY; Schneck JP; Green JJ
ACS Appl Mater Interfaces; 2021 Feb; 13(7):7913-7923. PubMed ID: 33573372
[TBL] [Abstract][Full Text] [Related]
10. Cell-Templated Silica Microparticles with Supported Lipid Bilayers as Artificial Antigen-Presenting Cells for T Cell Activation.
Olden BR; Perez CR; Wilson AL; Cardle II; Lin YS; Kaehr B; Gustafson JA; Jensen MC; Pun SH
Adv Healthc Mater; 2019 Jan; 8(2):e1801188. PubMed ID: 30549244
[TBL] [Abstract][Full Text] [Related]
11. DNA origami-based artificial antigen-presenting cells for adoptive T cell therapy.
Sun Y; Sun J; Xiao M; Lai W; Li L; Fan C; Pei H
Sci Adv; 2022 Dec; 8(48):eadd1106. PubMed ID: 36459554
[TBL] [Abstract][Full Text] [Related]
12. Fabrication of Anisotropic Polymeric Artificial Antigen Presenting Cells for CD8+ T Cell Activation.
Ben-Akiva E; Rhodes KR; Meyer RA; Green JJ
J Vis Exp; 2018 Oct; (140):. PubMed ID: 30371668
[TBL] [Abstract][Full Text] [Related]
13. Towards efficient cancer immunotherapy: advances in developing artificial antigen-presenting cells.
Eggermont LJ; Paulis LE; Tel J; Figdor CG
Trends Biotechnol; 2014 Sep; 32(9):456-65. PubMed ID: 24998519
[TBL] [Abstract][Full Text] [Related]
14. DNA Engineered Lymphocyte-Based Homologous Targeting Artificial Antigen-Presenting Cells for Personalized Cancer Immunotherapy.
Sun L; Shen F; Xiong Z; Yang H; Dong Z; Xiang J; Gu Q; Ji Q; Fan C; Liu Z
J Am Chem Soc; 2022 May; 144(17):7634-7645. PubMed ID: 35438987
[TBL] [Abstract][Full Text] [Related]
15. Size-transformable antigen-presenting cell-mimicking nanovesicles potentiate effective cancer immunotherapy.
Yang W; Deng H; Zhu S; Lau J; Tian R; Wang S; Zhou Z; Yu G; Rao L; He L; Ma Y; Chen X
Sci Adv; 2020 Dec; 6(50):. PubMed ID: 33310853
[TBL] [Abstract][Full Text] [Related]
16. Facile Transformation of Murine and Human Primary Dendritic Cells into Robust and Modular Artificial Antigen-Presenting Systems by Intracellular Hydrogelation.
Lin JC; Hsu CY; Chen JY; Fang ZS; Chen HW; Yao BY; Shiau GHM; Tsai JS; Gu M; Jung M; Lee TY; Hu CJ
Adv Mater; 2021 Jul; 33(30):e2101190. PubMed ID: 34096117
[TBL] [Abstract][Full Text] [Related]
17. Artificial Antigen-Presenting Cell Fabrication for Murine T Cell Expansion.
Omotoso MO; Lanis MR; Schneck JP
Curr Protoc; 2024 Feb; 4(2):e976. PubMed ID: 38400601
[TBL] [Abstract][Full Text] [Related]
18. A novel system of artificial antigen-presenting cells efficiently stimulates Flu peptide-specific cytotoxic T cells in vitro.
Han H; Peng JR; Chen PC; Gong L; Qiao SS; Wang WZ; Cui ZQ; Yu X; Wei YH; Leng XS
Biochem Biophys Res Commun; 2011 Aug; 411(3):530-5. PubMed ID: 21756876
[TBL] [Abstract][Full Text] [Related]
19. Artificial antigen-presenting cells expressing HLA class II molecules as an effective tool for amplifying human specific memory CD4(+) T cells.
Garnier A; Hamieh M; Drouet A; Leprince J; Vivien D; Frébourg T; Le Mauff B; Latouche JB; Toutirais O
Immunol Cell Biol; 2016 Aug; 94(7):662-72. PubMed ID: 26924643
[TBL] [Abstract][Full Text] [Related]
20. Nitric Oxide-Releasing Tubular Polymersomes toward Advanced Gas Therapeutic Carriers.
Li Z; Wang S; Zhao L; Gu J; Che H
ACS Macro Lett; 2024 Jan; 13(1):87-93. PubMed ID: 38174957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]